These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16382187)

  • 1. The serotonergic system and its role in cocaine addiction.
    Filip M; Frankowska M; Zaniewska M; Gołda A; Przegaliński E
    Pharmacol Rep; 2005; 57(6):685-700. PubMed ID: 16382187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
    Howell LL; Cunningham KA
    Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction.
    Nonkes LJ; van Bussel IP; Verheij MM; Homberg JR
    Behav Pharmacol; 2011 Dec; 22(8):723-38. PubMed ID: 22015806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.
    Müller CP; Carey RJ; Huston JP; De Souza Silva MA
    Prog Neurobiol; 2007 Feb; 81(3):133-78. PubMed ID: 17316955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.
    Belej T; Manji D; Sioutis S; Barros HM; Nobrega JN
    Brain Res; 1996 Oct; 736(1-2):287-96. PubMed ID: 8930335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine/serotonin releasers as medications for stimulant addictions.
    Rothman RB; Blough BE; Baumann MH
    Prog Brain Res; 2008; 172():385-406. PubMed ID: 18772043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Seger D
    Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
    Rothman RB; Blough BE; Baumann MH
    Trends Pharmacol Sci; 2006 Dec; 27(12):612-8. PubMed ID: 17056126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex.
    Huang CC; Liang YC; Lee CC; Wu MY; Hsu KS
    Neuropsychopharmacology; 2009 Jul; 34(8):1979-92. PubMed ID: 19212317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the 5-HT transporter contributes to the behavioural, neuronal and molecular effects of cocaine.
    Simmler LD; Anacker AMJ; Levin MH; Vaswani NM; Gresch PJ; Nackenoff AG; Anastasio NC; Stutz SJ; Cunningham KA; Wang J; Zhang B; Henry LK; Stewart A; Veenstra-VanderWeele J; Blakely RD
    Br J Pharmacol; 2017 Aug; 174(16):2716-2738. PubMed ID: 28585320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
    Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
    J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.
    Isingrini E; Perret L; Rainer Q; Sagueby S; Moquin L; Gratton A; Giros B
    J Psychiatry Neurosci; 2016 Apr; 41(3):169-81. PubMed ID: 26505143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys.
    Kohut SJ; Jacobs DS; Rothman RB; Partilla JS; Bergman J; Blough BE
    Psychopharmacology (Berl); 2017 Dec; 234(23-24):3455-3465. PubMed ID: 28889212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.
    Blough BE; Landavazo A; Decker AM; Partilla JS; Baumann MH; Rothman RB
    Psychopharmacology (Berl); 2014 Oct; 231(21):4135-44. PubMed ID: 24800892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioned rewarding stimulus associated with cocaine self-administration reverses the depression of catecholamine brain systems following cocaine withdrawal in rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Patsenka A; Papla I; Przegaliński E; Vetulani J
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):37-50. PubMed ID: 15941493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-substituted-6-amino-5-phenylbicyclo[2.2.2]octanes.
    Javanmard S; Deutsch HM; Collard DM; Kuhar MJ; Schweri MM
    J Med Chem; 1999 Nov; 42(23):4836-43. PubMed ID: 10579846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction.
    Filip M; Alenina N; Bader M; Przegaliński E
    Addict Biol; 2010 Jul; 15(3):227-49. PubMed ID: 20456287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.